Apolipoprotein E Genotype in Patients with Cerebrovascular Diseases and its Effect on the Disease Outcome

REFERENCES

• Alberts M. J., Graffagnino C., McClenny C., Delong D., Strittmatter W., Saunders A. M., et al. ApoE genotype and survival from intracerebral hemorrhage. Lancet 1995; 26: 575
   Google Scholar
• Attila G., Acarturk E., Eskandari G., Akpinar O., Tuli A., Kanadasi M., et al. Effects of apolipoprotein E genotypes and other risk factors on the development of coronary artery disease in Southern Turkey. Clinica Chimica Acta 2001; 312: 191–196
   PubMed Web of Science ®Google Scholar
• Brega A., Scacchi R., Cuccia M., Kirdar B., Peloso G., Corbo R. M. Study of 15 protein polymorphisms in a sample of the Turkish population. Human Biology 1998; 70: 715–728
   PubMedGoogle Scholar
• Catto A. J., McCormack L. J., Mansfield M. W., Carter A. M., Bamford J. M., Robinson P., et al. Apolipoprotein E polymorphism in cerebrovascular disease. Acta Neurologica Scandinavia 2000; 101: 399–404
   PubMed Web of Science ®Google Scholar
• Coria F., Rubio I., Nunez E., Sempere A. P., SantaEngarcia N., Bayon C., et al. Apolipoprotein E variants in ischemic stroke. Stroke 1995; 26: 2375–2376
   PubMed Web of Science ®Google Scholar
• Couderc R., Mahieux F., Bailleul S. Apolipoprotein E allele frequency in ischemic cerebrovascular disease and Alzheimer's disease. Stroke 1994; 24: 1416–1417
   Google Scholar
• Couderc R., Mahieux F., Bailleul S., Fenelon G., Mary R., Fermanian J. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study. Stroke 1993; 24: 661–664
   PubMedGoogle Scholar
• Di Carlo A., Lamassa M., Baldereschi M., Pracucci G., Consoli D., Wolfe C. D., et al. Risk factors and outcome of subtypes of ischemic stroke. Data from a multicenter multinational hospital-based registry. The European Community Stroke Project. Journal of the Neurological Sciences 2006; 244: 143–150
   PubMed Web of Science ®Google Scholar
• Dichgans M., Markus H. S. Genetic association studies in stroke. Methodological issues and proposed standard criteria. Stroke 2005; 36: 2027–2031
   PubMed Web of Science ®Google Scholar
• Duzenli S., Pirim I., Gepdiremen A., Denizci O. Apolipoprotein E polymorphism and stroke in a population from eastern Turkey. Journal of Neurogenetics 2004; 18: 365–375
   PubMed Web of Science ®Google Scholar
• Flossmann E., Rothwell P. M. Family history of stroke in patients with transient ischemic attack in relation to hypertension and other intermediate phenotypes. Stroke 2005; 36: 830–835
   PubMedGoogle Scholar
• Flossmann E., Schulz U. G. R., Rothwell P. M. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke 2004; 35: 212–227
   PubMed Web of Science ®Google Scholar
• Frank A., Díez-Tejedo E., Bullido M. J., Valdivieso F., Barreiro P. APOE genotype in cerebrovascular disease and vascular dementia. Journal of the Neurological Sciences 2002; 203–204: 173–176
   PubMedGoogle Scholar
• Gerdes L. U., Klausen I. C., Sihm I., Faergeman O. Apolipoprotein E polymorphism in a Danish population compared findings in 45 other study populations around the world. Genetic Epidemiology 1992; 9: 155–167
   PubMed Web of Science ®Google Scholar
• Graffagnino C., Gasecki A. P., Dog G. S., Hachinski V. C. The importance of family history in cerebrovascular disease. Stroke 1994; 25: 1599–1604
   PubMedGoogle Scholar
• Hoggart C. J., Parra E. J., Shriver M. D., Bonilla C., Kittles R. A., Clayton D. G., et al. Control of confounding of genetic associations in stratified populations. American Journal of Human Genetics 2003; 72: 1492–1500
   PubMed Web of Science ®Google Scholar
• Kiely D. K., Wolf P. A., Cupples L. A., Beiser A. S., Myrs R. H. Familial aggregation of stroke: the Framingham study. Stroke 1993; 24: 1366–1371
   PubMed Web of Science ®Google Scholar
• Kim J. S., Han S. R., Chung S. W., Kim B. S., Lee K. S., Kim Y. I., et al. The apolipoprotein E epsilon4 haplotype is an important predictor for recurrence in ischemic cerebrovascular disease. Journal of Neurological Sciences 2003; 206: 3–5
   PubMedGoogle Scholar
• Kuusisto J., Mykkanen L., Kervinen K., Kesaniemi Y. A., Laakso M. Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arteriosclerosis, Thrombosis, and Vascular Biology 1995; 15: 1280–1286
   PubMed Web of Science ®Google Scholar
• Lehtinen S., Luoma P., Lehtimaki T., Nayha S., Hassi J., Nikkari T. Differences in genetic variations of apolipoprotein E in Lapps and Finns. Atherosclerosis 1994; 109: 263–268
   Google Scholar
• Loimaala A., Rontu R., Vuori I., Mercuri M., Lehtimaki T., Nenonen A., et al. Blood leukocyte count is a risk factor for intima-media thickening and subclinical carotid atherosclerosis in middle-aged men. Atherosclerosis 2006; 188: 363–369
   PubMed Web of Science ®Google Scholar
• Mahley R. W., Huang Y. Apolipoprotein E: From atherosclerosis to Alzheimer's disease and beyond. Current Opinion in Lipidology 1999; 10: 207–217
   PubMed Web of Science ®Google Scholar
• Manke C., Schuster H, Keller C., Wolfram G. The effect of the apolipoprotein E polymorphism on lipid levels in patients with familial defective apolipoprotein B-100. The Clinical Investigator 1993; 71: 277–280
   PubMedGoogle Scholar
• McCarron M. O., Muir K. W., Nicoll J. A., Stewart J., Currie Y., Brown K., et al. Prospective study of apolipoprotein E genotype and functional outcome following ischemic stroke. Archives of Neurology 2000; 57: 1480–1484
   PubMedGoogle Scholar
• McCarron M. O., Muir K. W., Weir C. J., Dyker A. G., Bone I., Nicoll J. A., et al. The apolipoprotein E epsilon4 allele and outcome in cerebrovascular disease. Stroke 1998; 29: 1882–1887
   PubMed Web of Science ®Google Scholar
• Miyata M., Smith J. D. Apolipoprotein E allele-specific antioxidant activity and effects of cytotoxicity by oxidative insults and b-amyloid peptides. Nature Genetics 1996; 14: 55–61
   PubMed Web of Science ®Google Scholar
• Nakata Y., Katsuya T., Rakugi H., Takami S., Sato N., Kamide K., et al. Polymorphism of angiotensin converting enzyme, angiotensinogen, and apolipoprotein E genes in a Japanese population with cerebrovascular disease. American Journal of Hypertension 1997; 10: 1391–1395
   PubMed Web of Science ®Google Scholar
• Nathan B. P., Bellosta S., Sanan D. A., Weisgraber K. H., Mahley R. W., Pitas R. E. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 1994; 264: 850–852
   PubMed Web of Science ®Google Scholar
• Pedro-Botet J., Senti M., Nogues X., Rubies-Prat J., Roquer J., D'Olhaberriague L., et al. Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke 1992; 23: 1556–1562
   PubMed Web of Science ®Google Scholar
• Podgoreanu M. V., Schwinn D. A. New paradigms in cardiovascular medicine: Emerging technologies and practices: Perioperative genomics. Journal of the American College of Cardiology 2005; 46: 1965–1977
   PubMedGoogle Scholar
• Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends in Neuroscience 1994; 17: 525–530
   PubMed Web of Science ®Google Scholar
• Rubattu S., Gigante B., Stanzione R., De Paolis P., Tarasi D., Volpe M. In the search for stroke genes: a long and winding road. American Journal of Hypertension 2004; 17: 197–202
   PubMedGoogle Scholar
• Saunders A. M., Roses A. D. Apolipoprotein E allele frequency, ischemic cerebrovascular disease, and Alzheimer's disease. Stroke 1993; 24: 1416–1417
   PubMed Web of Science ®Google Scholar
• Schulz U. G. R., Flossmann E., Rothwell P. M. Heritability of ischemic stroke in relation to age, vascular risk factors, and subtypes of incident stroke in population-based studies. Stroke 2004; 35: 819–824
   PubMed Web of Science ®Google Scholar
• Sing C. F., Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. American Journal of Human Genetics 1985; 37: 268–285
   PubMed Web of Science ®Google Scholar
• Sklavounou E., Economou-Petersen E., Karadima G., Panas M., Avramopoulos D., Varsou A., et al. Apolipoprotein E polymorphism in the Greek population. Clinical Genetics 1997; 52: 216–218
   PubMed Web of Science ®Google Scholar
• Sprigg N., Gray L. J., Bath P. M., Lindenstrom E., Boysen G., De Deyn P. P., et al. Stroke severity, early recovery and outcome are each related with clinical classification of stroke: Data from the 'Tinzaparin in Acute Ischemic Stroke Trial' (TAIST). Journal of the Neurological Sciences 2007; 254: 54–59
   PubMedGoogle Scholar
• Stegmayr B., Asplund K., Kuulasmaa K., Rajakangas A. M., Thorvaldsen P., Tuomilehto J. Stroke incidence and mortality correlated to stroke risk factors in WHO MONICA Project: an ecological study of 18 populations. Stroke 1997; 28: 1367–1374
   PubMed Web of Science ®Google Scholar
• Tan C. E., Tai E. S., Tan C. S., Chia K. S., Lee J., Chew S. K., et al. APOE polymorphism and lipid profile in three ethnic groups in the Singapore population. Atherosclerosis 2003; 170: 253–260
   PubMedGoogle Scholar
• Tanaka H., Yokoyama T. Cerebrovascular disease. Oxford Textbook of Public Health, R. Detels, W. W. Holland. Oxford University Press, Oxford 1997; 1065–1079
   Google Scholar
• Tang J., Zhao J., Zhao Y., Wang S., Chen B., Zeng W. Apolipoprotein E epsilon 4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage. Surgical Neurology 2003; 60: 391–396
   PubMedGoogle Scholar
• Tiret L., de-Knijff P., Menzel H. J., Ehnhollm C., Nicaud V., Havekes L. M. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS study. European atherosclerosis research study. Arteriosclerosis and Thrombosis 1994; 14: 1617–1624
   PubMed Web of Science ®Google Scholar
• Tonk M., Haan J. A review of genetic causes of ischemic and hemorrhagic stroke. Journal of the Neurological Sciences 2007; 257: 273–279
   PubMed Web of Science ®Google Scholar
• Troen A. M. The central nervous system in animal models of hyperhomocysteinemia. Progress in Neuropsychopharmacology and Biological Psychiatry 2005; 29: 1140–1151
   PubMed Web of Science ®Google Scholar
• Van Stavern R. B. Primary intracerebral hemorrhage: Natural history, prognosis, and outcomes. Seminars in Cerebrovascular Disease and Stroke 2005; 5: 163–167
   Google Scholar
• Woo D., Sauerbeck L. R., Kissela B. M., Khoury J. C., Szaflarski J. P., Gebel J., et al. Genetic and environmental risk factors for intracerebral hemorrhage. Preliminary results of a population-based study. Stroke 2002; 33: 1190–1196
   PubMed Web of Science ®Google Scholar
• XuGuang G., Yang H., Zhiping T. Association studies of genetic polymorphism, environmental factors and their interaction in ischemic stroke. Neuroscience Letters 2006; 398: 172–177
   PubMedGoogle Scholar